U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 19

1.

Progressive degeneration of human neural stem cells caused by pathogenic LRRK2

(Submitter supplied) Aging and its physiological manifestations have been correlated with adult stem cell exhaustion and a failure to maintain tissue homeostasis1-10. Since multiple morphological cellular defects are associated with aging-related disorders, we hypothesized that late onset disorders might be linked to adult stem cell abnormalities compromising cellular function over time. Our work shows that a dominant G2019S mutation in the human LRRK2 gene, which is associated with central nervous system disorders, including Parkinson’s disease, the second most prevalent neurodegenerative disease in the aging population, causes alterations in neural stem cell homeostasis in aging-related cellular contexts. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL11154
6 Samples
Download data: BED, BW
Series
Accession:
GSE34061
ID:
200034061
2.

Gene expression analysis of H9 hESC derived neuron stem cells (NSC) harboring pathogenic LRRK2 (G2019S) mutation

(Submitter supplied) Genetic mutations on leucine-rich repeat kinase 2 (LRRK2) have been associated with an increased risk of Parkinson's disease. The Gly2019Ser (G2019S) mutation on LRRK2 gene is a relatively common cause of familial Parkinson's disease in Caucasian population. In this study, we generated H9 hESC harboring LRRK2 (G2019S) mutation by gene knockin. Wildtype and LRRK2 mutant hESC were differentiated into NSC using a chemically defined protocol.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4401
Platform:
GPL571
9 Samples
Download data: CEL
Series
Accession:
GSE36321
ID:
200036321
3.

Gene expression analysis of human iPSC generated from pathogenic LRRK2 (G2019S) mutation bearing patients

(Submitter supplied) Genetic mutations on leucine-rich repeat kinase 2 (LRRK2) have been associated with an increased risk of Parkinson's disease. The Gly2019Ser (G2019S) mutation on LRRK2 gene is a relatively common cause of familial Parkinson's disease in Caucasian population. In this study, we generated human induced pluripotent stem cell (iPSC) lines from LRRK2 (G2019S) bearing patient fibroblasts by cell reprogramming. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4400
Platform:
GPL571
14 Samples
Download data: CEL
Series
Accession:
GSE33298
ID:
200033298
4.
Full record GDS4401

H9 hESC-derived neural stem cells harboring pathogenic leucine-rich repeat kinase 2 mutation

Analysis of LRRK2 (Gly2019Ser) mutant neural stem cells (NSC) treated with LRRK2 kinase specific inhibitor LRRK2-IN-1. The LRRK2 (G2019S) mutation causes familial Parkinson's disease. Results provide insight into molecular basis of progressive degeneration of NSCs caused by pathogenic LRRK2.
Organism:
Homo sapiens
Type:
Expression profiling by array, count, 2 agent, 2 genotype/variation sets
Platform:
GPL571
Series:
GSE36321
9 Samples
Download data: CEL
5.
Full record GDS4400

Fibroblast-derived induced pluripotent stem cells harboring pathogenic leucine-rich repeat kinase 2 mutation

Analysis of IPSCs generated from LRRK2 (Gly2019Ser) mutation-bearing patient fibroblasts by cell reprogramming. The LRRK2 (G2019S) mutation causes familial Parkinson's disease (PD). Results provide insight into the molecular mechanisms underlying PD.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 3 cell type, 3 genotype/variation sets
Platform:
GPL571
Series:
GSE33298
14 Samples
Download data: CEL
6.

in-vitro differentiated midbrain dopaminergic neurons from isogenic human induced pluripotent stem cells

(Submitter supplied) We have generated isogenic induced pluripotent stem cell lines by reprogramming human fibroblasts from patients carrying the LRRK2 G2019S mutation with subsequent zinc finger nuclease - mediated targeted correction of the diseased allele. These iPS cell lines were differentiated for 30 days using a direct differentiation protocol towards midbrain dopaminergic neurons (mDANs).
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
8 Samples
Download data: TXT
Series
Accession:
GSE43364
ID:
200043364
7.

Derivation, characterization, and neuronal differentiation of integration-free induced pluripotent stem cell lines from Parkinsons disease patients carrying SNCA, LRRK2, PARK2, and GBA mutations

(Submitter supplied) Analysis of whole genome expression in control and patients with Parkinsons disease iPSC lines. The hypothesis tested in present study was that deficient GBA, SNCA, LRRK2 and PARKIN expression can be used for disease modeling by their affects on multiple pathways. These results provide information on relationship between PD genes and mitochondria related gene expression.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
8 Samples
Download data: TXT
Series
Accession:
GSE78152
ID:
200078152
8.

Neural stem cells of Parkinson’s disease patients exhibit aberrant mitochondrial morphology and functionality

(Submitter supplied) Emerging evidence suggest that Parkinson's disease (PD), besides being an age-associated disorder, might also have a neurodevelopment component. Disruption of mitochondrial homeostasis has been highlighted as a crucial cofactor in its etiology. Here, we show that PD patient-specific human neuroepithelial stem cells (NESCs) carrying the LRRK2-G2019S mutation recapitulate key mitochondrial defects previously described only in differentiated dopaminergic neurons. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18573
2 Samples
Download data: TXT
Series
Accession:
GSE128040
ID:
200128040
9.

The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson’s disease

(Submitter supplied) Astrocytes are essential cells of the central nervous system, characterized by dynamic relationships with neurons that range from functional metabolic interactions and regulation of neuronal firing activities, to the release of neurotrophic and neuroprotective factors. In Parkinson’s disease (PD), dopaminergic neurons are a vulnerable population progressively lost during the course of the disease, but the effects of PD on astrocytes and astrocyte-to-neuron communication remains mostly unknown. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL21697
27 Samples
Download data: XLSX
Series
Accession:
GSE152768
ID:
200152768
10.

RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes

(Submitter supplied) Non-neuronal cell types such as astrocytes can contribute to Parkinson’s disease (PD) pathology. The G2019S mutation in leucine-rich repeat kinase 2 (LRRK2) is one of the most common known causes of familial PD. To characterize its effect on astrocytes, we developed a protocol to produce midbrain-patterned astrocytes from human induced pluripotent stem cells (iPSCs) derived from PD LRRK2 G2019S patients and healthy controls. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL20301
7 Samples
Download data: TXT
Series
Accession:
GSE120306
ID:
200120306
11.

Idiopathic and LRRK2-associated Parkinson's disease

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array; Methylation profiling by array
Platforms:
GPL13534 GPL5175
42 Samples
Download data: CEL
Series
Accession:
GSE51923
ID:
200051923
12.

Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease (PD)

(Submitter supplied) We analysed the RNA profile of IPSC-derived dopaminergic neurons from idiophatic and genetic form (LRRK2) of Parkinson’s disease (PD). Both, idiopathic and genetic form of the disease show similar expression alterations and were merged in one whole PD group. We found 437 differentially expressed genes (DEGs) in the PD group as a whole. Up-regulated DEGs (n=254) encompassed genes involved in neural functions and transcription factor functions whereas down-regulated DEGs (n=183) affected basic homeostasis. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL5175
14 Samples
Download data: CEL
Series
Accession:
GSE51922
ID:
200051922
13.

DNA methylation analysis in idiopathic and LRRK2-associated Parkinson's disease (PD)

(Submitter supplied) We performed a genome-wide DNA methylation study in induced pluripotent stem cells (IPSC)-derived dopaminergic neurons (DAn) generated from keratinocytes of monogenic and sporadic Parkinson disease (PD) patients as well as of healthy subjects. We observed extensive DNA methylation changes in DAn from PD patients. These changes were neither present in the original keratinocytes nor in the undifferentiated IPSCs, suggesting latent molecular defects in PD keratinocytes that are manifested only upon differentiation into DAn. more...
Organism:
Homo sapiens
Type:
Methylation profiling by array
Platform:
GPL13534
28 Samples
Download data: TXT
Series
Accession:
GSE51921
ID:
200051921
14.

Transcriptome analysis of IPSC and NPC, derived from twins, discordant by PD

(Submitter supplied) This submission contains a result of a study of transcriptiomic profiles of the IPSC and NPC, derived from PD discordant monozygous twins.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18460
24 Samples
Download data: TXT
15.

RNA-seq, RRBS-seq and miRNA-seq study of Parkinson's disease patients

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Methylation profiling by high throughput sequencing; Non-coding RNA profiling by high throughput sequencing
Platform:
GPL15433
201 Samples
Download data: TXT
Series
Accession:
GSE110720
ID:
200110720
16.

Small RNA profiling from cultured cells and tissues derived from Parkinson's disease patient [small RNA-seq]

(Submitter supplied) High throughput sequencing of small RNAs (mature miRNA and piRNA/piRNA-like molecules) from control- and sporadic Parkinson´s disease patient derived fibroblasts (n=15), induced pluripotent stem cells (n=26) and differentiated midbrain neurons (n=10). In parallel, cingulate gyrus samples from eight control- and eight Parkinson´s disease patients obtained from the Netherlands Brain Bank were sequenced. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL15433
69 Samples
Download data: TXT
Series
Accession:
GSE110719
ID:
200110719
17.

Reduced representation bisulfite sequencing (RRBS) of cultured cells derived from Parkinson's disease patient [RRBS-seq]

(Submitter supplied) High throughput sequencing of MSPI digested, size selected and bisulfite converted genomic DNA from control- and sporadic Parkinson´s disease patient derived fibroblasts (n=15), induced pluripotent stem cells (n=26) and differentiated midbrain neurons (n=10). We were able to sequence more than 400,000 CpGs at ≥5x coverage in all samples. Nonetheless, statistical analysis with RnBeads did not identify major differences on single CpG or promoter methylation level between control- and Parkinson´s disease patient derived cells in any cell type.
Organism:
Homo sapiens
Type:
Methylation profiling by high throughput sequencing
Platform:
GPL15433
53 Samples
Download data: TXT
Series
Accession:
GSE110718
ID:
200110718
18.

RNA-seq of cultured cells derived from Parkinson's disease patients [PolyA RNA-seq]

(Submitter supplied) High throughput sequencing of poly-A RNA from control- and sporadic Parkinson´s disease patient derived fibroblasts (n=15), induced pluripotent stem cells (n=31) and differentiated midbrain neurons (n=15). Fibroblasts and iPSCs do not show major differences on single gene level. In contrast, midbrain neurons derived from Parkinson´s disease patients show changes known to be associated with neurodegenerative diseases.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL15433
63 Samples
Download data: TXT
Series
Accession:
GSE110717
ID:
200110717
19.

RNA-seq of brain tissue from Parkinson's disease patients [coding exome RNA-seq]

(Submitter supplied) High throughput sequencing of coding exome RNA from cingylate gyrus brain tissue obtained from control- and Parkinson´s disease patients. In the Parkinson´s disease affected tissue, changes are present that are known to be related to the pathogenesis of neurodegenerative diseases.
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL15433
16 Samples
Download data: TXT
Series
Accession:
GSE110716
ID:
200110716
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=2|blobid=MCID_66566fbce795547e5fd2d856|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center